Tetraphase Pharmaceuticals, Inc. (TTPH)

[Schnauzer1]

However, I should hasten to add that the exclusive license for synthetic manufacturing of Tetracycline should be valued quite a bit higher. Not to mention the 3000 derivatives they have in the lab already. I think given the acquisition storm brewing in pharma we could see a significant bid for this stock! That is the outlier here! That likelyhood increases as Congress sweetens the tax benefits for research into antibiotics! Good luck